Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients

ReporterLens™ analysis of "Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients" — Breitbart. Advocate archetype. Emotional tone 5/10. Attribution 3/10. Headline accuracy 4/10. Read the full ReporterLens™ breakdown of sourcing, evidence, and narrative framing.